Enoxaparin sodium

TargetMol
Product Code: TAR-T22323
Supplier: TargetMol
CodeSizePrice
TAR-T22323-1mg1mg£95.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T22323-2mg2mg£106.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T22323-5mg5mg£128.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T22323-10mg10mg£161.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T22323-25mg25mg£262.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T22323-50mg50mg£349.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T22323-100mg100mg£503.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T22323-200mg200mg£687.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Further Information

Bioactivity:
Enoxaparin sodium is a low-molecular-weight heparin (LMWH) that has recently been approved by the US FDA for use in patients with medically managed ST-segment myocardial infarction (STEMI), or STEMI with subsequent percutaneous coronary intervention (PCI). It binds to and potentiates the action of antithrombin, and inhibits coagulation factors XIa, IXa, Xa and IIa (thrombin), thereby preventing formation of blood clots.
CAS:
679809-58-6
Formula:
C42H59N3Na4O35S2
Molecular Weight:
1322
Pathway:
Proteases/Proteasome
Purity:
0.98
SMILES:
[Na+].[Na+].[Na+].[Na+].C[C@@H]1[C@@H](NC(C)=O)[C@@H](OC2[C@H](O)[C@@H](O)[C@H](OC3[C@H]4CO[C@H](O4)[C@H](NS([O-])(=O)=O)[C@H]3O)OC2C([O-])=O)O[C@H](CO)[C@H]1O[C@@H]1CC([C@@H](O[C@H]2O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]3OC(=C[C@H](O)[C@H]3O)C([O-])=O)[C@H](
Target:
Thrombin

References

1. Carter NJ, McCormack PL, Plosker GL. Enoxaparin: a review of its use in ST-segment elevation myocardial infarction. Drugs. 2008;68(5):691-710.